ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................J0009290-CORR013701956CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120240717W173deBibliographieenBibliographyfrBibliographieEP18870872.1201805142020042120230413jaenen201720837620171027JP2024071720242920200902202036202406262024262024010520240717202429A61K 33/00 20060101AFI20210607BHEP A61P 25/28 20060101ALI20210607BHEP A61K 9/00 20060101ALI20210607BHEP A61K 33/00 20130101 LI20190530BHEP A61P 25/28 20180101 LI20190530BHEP A61K 9/007 20130101 FI20210601BHEP dePROPHYLAKTISCHES UND/ODER THERAPEUTISCHES MITTEL BEI DEMENZenPROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR DEMENTIAfrAGENT PROPHYLACTIQUE ET/OU THÉRAPEUTIQUE CONTRE LA DÉMENCEEP-A1- 1 946 762EP-B1- 1 946 762JP-A- 2009 114 084JP-A- 2009 114 084JP-A- 2015 183 005JP-A- 2018 030 804US-A1- 2015 272 867CAI WANG ET AL: "Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-B activation in a rat model of amyloid-beta-induced Alzheimer's disease", NEUROSCIENCE LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 491, no. 2, 7 January 2011 (2011-01-07), pages 127 - 132, XP028145405, ISSN: 0304-3940, [retrieved on 20110114], DOI: 10.1016/J.NEULET.2011.01.022LI J ET AL: "Hydrogen-rich saline improves memory function in a rat model of amyloid-beta-induced Alzheimer's disease by reduction of oxidative stress", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 1328, 30 April 2010 (2010-04-30), pages 152 - 161, XP026999980, ISSN: 0006-8993, [retrieved on 20100219]RYUJI YONAMINE ET AL: "Coadministration of Hydrogen Gas as Part of the Carrier Gas Mixture Suppresses Neuronal Apoptosis and Subsequent Behavioral Deficits Caused by Neonatal Exposure to Sevoflurane in Mice", ANESTHESIOLOGY, vol. 118, no. 1, 1 January 2013 (2013-01-01), pages 105 - 113, XP055178856, ISSN: 0003-3022, DOI: 10.1097/ALN.0b013e318275146dKIYOMI NISHIMAKI ET AL: "Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment", CURRENT ALZHEIMER RESEARCH, vol. 15, no. 5, 14 March 2018 (2018-03-14), NL, pages 482 - 492, XP055661340, ISSN: 1567-2050, DOI: 10.2174/1567205014666171106145017KYOTA FUJITA ET AL: "Therapeutic Approach to Neurodegenerative Diseases by Medical Gases: Focusing on Redox Signaling and Related Antioxidant Enzymes", OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, vol. 2012, 1 January 2012 (2012-01-01), US, pages 1 - 9, XP055631635, ISSN: 1942-0900, DOI: 10.1155/2012/324256CHENG-LIN LIU ET AL: "Hydrogen therapy: from mechanism to cerebral diseases", MEDICAL GAS RESEARCH, vol. 6, no. 1, 1 March 2016 (2016-03-01), London, UK, pages 48 - 54, XP055596903, ISSN: 2045-9912, DOI: 10.4103/2045-9912.179346CHENG, LIN-LIU: "Hydrogen therapy: from mechanism to cerebral diseases", MEDICAL GAS RESEARCH, vol. 6, no. 1, March 2016 (2016-03-01), pages 48 - 54, XP055596903OHTA, SHIGEO ET AL.: "Recent progress toward hydrogen medicine: potential of molecular hydrogen for preventive and therapeutic applications", CURRENT PHARMACEUTICAL DESIGN, vol. 17, 2011, pages 2241 - 2252, XP055535704, DOI: 10.2174/138161211797052664SHIGEO OTA: "5. Ninshishō no yobō [Prevention of dementia]", NEWSLETTER, vol. 1, 2010, pages 1 - 4, XP009520108, Retrieved from the Internet <URL:http://www2.nms.ac.jp/ig/soudan/hpb/pdf/Newsletter1012.pdf>20210611ONO, Hirohisac/o Nishijima Hospital, Medical Corporation Association Shinwakai, 2835-7, OookaNumazu-shi Shizuoka 4100022JPNISHIJIMA, Yojic/o Nishijima Hospital, Medical Corporation Association Shinwakai, 2835-7, OookaNumazu-shi Shizuoka 4100022JPOHTA, ShigeoS3309 3-1100-15 Shinmarukohigashi Nakahara-kuKawasaki-shi Kanagawa 211-0004JPASADA, Takashi1-5-34, Yushima, Bunkyo-kuTokyo 113-0034JPH2 Global Group s.r.o.102046713007666266Muglinovská 154/73Muglinov 712 00 OstravaCZMewburn Ellis LLP101783151Aurora Building CounterslipBristol BS1 6BXGBALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRJP201801848320180514jaWO20190824282019050220191820240606